Category Archives: Cancer

Paying Tribute to a Warrior Against Big Pharma: Zahara Heckscher

Source: Public Citizen | By Melinda St. Louis Peaceful warrior Zahara Heckscher, who passed away on February 24 at the age of 53, after her years-long battle with breast cancer. Among her many talents as a writer, poet, teacher and facilitator, Zahara was … Continue reading

Posted in Bad Pharma, Cancer, Uncategorized | Leave a comment

Cancer Drug Price Rises 1, 400% With No Generic to Challenge It

By Peter Loftus, Wall Street Journal Since 2013, the price of a 40-year-old, off-patent cancer drug in the U.S. has risen 1,400%, putting the life-extending medicine out of reach for some patients. Introduced in 1976 to treat brain tumors and Hodgkin … Continue reading

Posted in Cancer, Drug prices, Generics, Price hikes, Uncategorized | Leave a comment

Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group

Source: Bloomberg Gilead Sciences Inc.’s U.S. patents on the blockbuster $84,000 hepatitis C treatment Sovaldi were challenged by a consumer group that’s battled the drugmaker around the world over the pricing.  The Initiative for Medicines, Access & Knowledge, a nonprofit focused on … Continue reading

Posted in Cancer, Evergreening, Hepatitis C, Patent, Uncategorized | Leave a comment

Greek health minister takes issue with Roche’s withdrawal of cancer medicine due to mandatory, retroactive discount

Source: EndPoints News Drug prices are not just a US problem. Greece’s minister of health on Tuesday expressed dismay over Roche’s decision to withdraw a cancer medicine because of a new mandatory discount imposed by the country. Greek health minister … Continue reading

Posted in Cancer, Compulsory Licensing, Patent, TRIPS, Uncategorized | 1 Comment

Africa’s cancer curse: Cipla shows way again

By Donald G. Mcneil Jr, International New York Times , Oct 10 2017 In a deal similar to the one that turned the tide against AIDS, Pfizer and Cipla will make chemotherapy drugs available in six poor countries at steep … Continue reading

Posted in Cancer, Uncategorized | Leave a comment

Patient commentary: the current model has failed

Source: BMJ The cost of cancer drugs is skyrocketing: prices of cancer drugs increased by 10% every year between 1995 and 2013.1 More and more we’re seeing cancer drugs being priced off the NHS—as is the case with secondary breast cancer … Continue reading

Posted in Cancer, Drug prices, R&D, Uncategorized | Leave a comment


Today, UACT submitted letters to the CEOs of three major pharmaceutical companies currently developing chimeric antigen receptor T-cell (CAR T) technologies.  UACT asked the leaders of Novartis, Gilead Sciences, and Juno Therapeutics to address questions regarding research and development (R&D) … Continue reading

Posted in Cancer, Drug prices, Gene Therapy, Patent, R&D, Uncategorized | Leave a comment